Nitric oxide and cisplatin resistance: NO easy answers
- 13 March 2006
- journal article
- editorial
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 103 (12) , 4337-4338
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Reversal to cisplatin sensitivity in recurrent human ovarian cancer cells by NCX-4016, a nitro derivative of aspirinProceedings of the National Academy of Sciences, 2006
- Nitric Oxide-Donating Aspirin Inhibits Colon Cancer Cell Growth via Mitogen-Activated Protein Kinase ActivationThe Journal of Pharmacology and Experimental Therapeutics, 2006
- Nitric oxide-donating aspirin induces apoptosis in human colon cancer cells through induction of oxidative stressProceedings of the National Academy of Sciences, 2005
- Positional Isomerism Markedly Affects the Growth Inhibition of Colon Cancer Cells by Nitric Oxide-Donating Aspirin in Vitro and in VivoThe Journal of Pharmacology and Experimental Therapeutics, 2005
- In Vitro Metabolism of Nitric Oxide-Donating Aspirin: The Effect of Positional IsomerismThe Journal of Pharmacology and Experimental Therapeutics, 2005
- Glutathione S‐Transferases as Regulators of Kinase Pathways and Anticancer Drug Targets2005
- NO-donating nonsteroidal antiinflammatory drugs (NSAIDs) inhibit colon cancer cell growth more potently than traditional NSAIDs: a general pharmacological property?Biochemical Pharmacology, 2004
- Nitric Oxide Donors and Cardiovascular Agents Modulating the Bioactivity of Nitric OxideCirculation Research, 2002
- Role of p42/p44 mitogen-activated-protein kinase and p21 waf1/cip1 in the regulation of vascular smooth muscle cell proliferation by nitric oxideProceedings of the National Academy of Sciences, 2001
- Nitric Oxide and Some Nitric Oxide Donor Compounds Enhance the Cytotoxicity of CisplatinNitric Oxide, 1997